SCHEMBL2397583

SCHEMBL2397583

CCOC(=O)CC[PH](=O)CO

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.45
GAA P10253 2/20 0.44
MGAM O43451 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
CYP4F2 P78329 3/20 0.42
CYP4A11 Q02928 3/20 0.42
ALDH1A1 P00352 5/20 0.41
TRPA1 O75762 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 2/20 0.39
POLB P06746 2/20 0.39
NR1I2 O75469 1/20 0.37
PGR P06401 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
PTGS2 P35354 1/20 0.37
PDE4D Q08499 1/20 0.37
LMNA P02545 2/20 0.36
TSHR P16473 2/20 0.36
HSD17B10 Q99714 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11407515 0.89 GAA (0.50) CYP1A2GAAMGAMSIMGAM2
SCHEMBL9067737 0.85 TSHR (0.49) CYP1A2GAACYP4F2CYP4A11ALDH1A1
SCHEMBL2397291 0.84 DGKA (0.42) ALDH1A1L3MBTL1
SCHEMBL2397923 0.81 DGKA (0.48) ALDH1A1TSHR
SCHEMBL8528852 0.81 L3MBTL1 (0.44) CYP1A2GAAMGAMSIMGAM2
SCHEMBL11023018 0.80 FAAH (0.41) CYP1A2GAAMGAMSIMGAM2
SCHEMBL11025210 0.80 CYP1A2 (0.42) CYP1A2GAAMGAMSIMGAM2
SCHEMBL16049200 0.79 CYP1A2 (0.41) CYP1A2GAAMGAMSIMGAM2
SCHEMBL28647620 0.78 CYP1A2 (0.48) CYP1A2GAAMGAMSIMGAM2
SCHEMBL26199390 0.76 CYP1A2 (0.47) CYP1A2GAAMGAMSIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2133356-B1 PROCESS FOR PRODUCTION OF PHOSPHORUS-CONTAINING -KETO ACID MEIJI SEIKA PHARMA CO LTD (JP) 2014-09-24 EP disclosed
US-8017797-B2 Method for producing phosphorus-containing α-keto acid MEIJI SEIKA KAISHA LTD. (JP) 2011-09-13 US disclosed
US-20100063313-A1 METHOD FOR PRODUCING PHOSPHORUS-CONTAINING ALPHA-KETO ACID MEIJI SEIKA KAISHA LTD., (JP) 2010-03-11 US disclosed
EP-2133356-A1 PROCESS FOR PRODUCTION OF PHOSPHORUS-CONTAINING -KETO ACID Meiji Seika Kaisha, Ltd. (JP) 2009-12-16 EP disclosed
EP-0030424-B1 DERIVATIVES OF 4-(METHYLPHOSPHINYL)-2-OXOBUTANOIC ACID, HERBICIDAL COMPOSITIONS CONTAINING THEM, AND INTERMEDIATES AND METHODS FOR THEIR PRODUCTION HOECHST AKTIENGESELLSCHAFT (DE) 1985-02-20 EP disclosed
US-4399287-A POSTEMERGENCE HERBICIDES; PESTICIDES; PLANT GROWTH REGULATORS; DESICCANTS FBC LIMITED (GB) 1983-08-16 US disclosed
EP-0030424-A2 Derivatives of 4-(methylphosphinyl)-2-oxobutanoic acid, herbicidal compositions containing them, and intermediates and methods for their production HOECHST AKTIENGESELLSCHAFT (DE) 1981-06-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063313-A1 METHOD FOR PRODUCING PHOSPHORUS-CONTAINING ALPHA-KETO ACID PRKAB1, PRKAB2, PLCB1 CYP1A2 1483/4885GAA 956/4885MGAM 259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.